Pharmacists' Utilization of Non-HDL-C Levels in Managing Patients With Lipid Disorders.

ABSTRACT: Background: Since 2013 there have been cholesterol guideline changes impacting pharmacists' clinical practice in managing lipid disorders. For more than a decade, cholesterol management was based on the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol Adult Treatment Panel III guideline, highlighting non-high-density lipoprotein cholesterol (non-HDL-C) as a secondary target in persons with triglycerides ≥200 mg/dL, after low-density lipoprotein cholesterol goal attainment. The 2013 American College of Cardiology and American Heart Association (ACC/AHA) guideline differed from the traditional management of dyslipidemia, in part no longer emphasizing the utilization of non-HDL-C levels. Objective: To measure p

SUBMITTER: Plakogiannis R 

PROVIDER: S-EPMC8326872 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature